Rare diseases
Investigational molecules
Locations
Back to the Netherlands22 clinical trials in Tiel, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
The NetherlandsLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
The NetherlandsComparison of atropine 0.
The NetherlandsStudy Comparing Two Treatment Sequences of CDK4/6 Inhibitors (Abemaciclib, Palbociclib, or Ribociclib) in Hormone Receptor Positive Advanced Breast Cancer
The NetherlandsStudy of Trastuzumab, Pertuzumab, and Chemotherapy Combination with Response-Guided Treatment for Patients with HER2-Positive Breast Cancer
The NetherlandsStudy on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease
The NetherlandsStudy Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients
The NetherlandsStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
The NetherlandsStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
The NetherlandsStudy on Liposomal Irinotecan, Carboplatin, or Oxaliplatin for First-Line Treatment in Patients with Advanced Esophagogastric Cancer
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on cardiovascular disease prevention and treatment, including innovative approaches for reducing major adverse cardiac events.
Multiple trials evaluating novel therapeutics for patients with established cardiovascular conditions, emphasizing preventive strategies and improved outcomes.
Groundbreaking research in blood cancer treatments, particularly focusing on chronic lymphocytic leukemia and multiple myeloma.
Studies exploring fixed-duration treatments versus adaptive approaches based on minimal residual disease monitoring.
Advanced clinical trials investigating targeted therapies for HER2-positive and hormone receptor-positive breast cancer.
Innovative approaches to treatment optimization, including image-guided therapy de-escalation strategies.
Research focusing on esophagogastric cancer treatment strategies, evaluating various chemotherapy combinations.
Trials comparing different chemotherapy regimens to optimize treatment outcomes and reduce side effects.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
